HCP Connect Clinical Author
Dr. Deepak Nair
Rheumatology
Specialty
Rheumatology
Clinical Updates
15
Experience
7 Years
Author Biography
About Dr. Deepak Nair
Dr. Deepak Nair is a rheumatologist with 7 years of clinical experience. He completed a DM in Clinical Immunology and Rheumatology following an MD in General Medicine, focusing on rheumatoid arthritis, lupus, and spondyloarthritis. He follows the expanding role of biologics and targeted synthetic DMARDs closely. His writing helps clinicians navigate complex autoimmune disease.
Published Work
Recent Clinical Updates
15 articles
Rheumatology
FDA Approves Subcutaneous Anifrolumab for Moderate-to-Severe SLE
anifrolumab systemic lupus erythematosus: FDA approved subcutaneous Saphnelo (120 mg weekly) for adults with moderate-to-severe SLE, expanding delivery options.
Rheumatology
Deucravacitinib Label Adds Psoriatic Arthritis; ACR20 54.2% in POETYK
deucravacitinib psoriatic arthritis: FDA label update 03/2026; POETYK PsA trials showed ACR20 54.2% vs placebo at Week 16. Safety: infections, CPK increase, herpes simplex.
Rheumatology
Golimumab Biosimilars Update: FDA OKs Interchangeable Immgolis for RA and UC
golimumab rheumatoid arthritis: FDA approves interchangeable Immgolis for RA and UC; Trial RA showed 59% ACR20 with golimumab + MTX vs 25% [8][11].
Rheumatology
FDA Approves Immgolis for RA and UC: 59% ACR20 in Trial RA
Immgolis (golimumab-sldi) approved as interchangeable biosimilar to Simponi for RA and UC; Trial RA showed 59% ACR20 vs 25% placebo at Week 14.
Medical Research
Eradicate Neuroblastoma with 100% Response Rate
Discover how a novel approach achieves complete responses in neuroblastoma, overcoming cancer cell plasticity and indisulam resistance, for improved patient outcomes.
Health Policy
Improve Outcomes for Students With Disabilities
Discover how federal policies impact support for students with disabilities and learn strategies to improve their educational and vocational outcomes.
Healthcare Business
Cut GLP-1 RA Dropout Rates by 50% with Targeted Interventions
Discover how to improve patient adherence to GLP-1 RA therapy, reducing dropout rates and optimizing treatment outcomes for diabetes and weight loss management.
Medical Research
Identify Liver Disease in 70% of Type 2 Diabetics
Learn about metabolic dysfunction–associated steatotic liver disease, a silent pandemic affecting 1 in 3 adults and 70% of type 2 diabetics worldwide.
Medical Research
Cystitis May Signal Urogenital Cancer Risk
New research suggests a bout of cystitis may indicate urogenital cancer in middle-aged adults, particularly within 3 months of infection.
Medical Research
Improve ADHD Treatment in Young Kids with 6-Month Therapy
Discover how delaying medication and using behavior therapy first can improve treatment outcomes for 4- and 5-year-olds with ADHD, closing the gap in medical care.
Healthcare Business
Vaccine Confidence: 37% of Parents Doubt Safety
Understand the latest trends in parental confidence in childhood vaccines, and how misinformation affects vaccination rates among children under 6 years old.
Pharmaceutical
New Lung Disease Treatment Fails to Reduce Steroid Use
Experimental drug efzofitimod misses Phase 3 trial goal, failing to significantly cut steroid use in pulmonary sarcoidosis patients, impacting treatment options.
Medical Research
Cut Heart Failure Readmissions by 25% with In-Home Care
Reduce hospital readmissions for heart failure patients with mobile integrated health, benefiting women and younger patients with targeted in-home follow-up care.
Medical Research
Identify Kids at Risk: Parental Despair Linked to Suicidal Events
New study reveals link between parental diseases of despair and suicidal events in offspring, informing early intervention and prevention strategies for at-risk youth.
Immunology
Macrophages Drive Fat Cell Differentiation
Discover how macrophages contribute to adipose tissue function and fat cell differentiation in new research findings